Revvity Inc

Research Revvity Inc (RVTY) on Bullrun: valuation model: 21.4% overvalued, market cap USD 12.41B, P/E 52.7, dividend yield 0.3%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerRVTY
• ExchangeNYSE
• CountryUnited States
• SectorHealthcare
• IndustryDiagnostics & Research
• CurrencyUSD
• Valuation signal21.4% overvalued
• Market capUSD 12.41B
• P/E52.7
• Dividend yield0.3%
• Financial periodFY2025
• RevenueUSD 2.86B
• Revenue growth3.7%
• Net incomeUSD 241.20M
• Free cash flowUSD 509.41M

Valuation Snapshot

Bullrun's latest valuation model marks Revvity Inc as 21.4% overvalued; latest market cap is USD 12.41B; P/E is 52.7; dividend yield is 0.3%.

About Revvity Inc

Revvity, Inc. provides health sciences solutions, technologies, and services. The company offers instruments, reagents, software, subscriptions, detection and imaging technologies, extended warranties, training and services; and instruments, reagents, assay platforms and software products for early detection of common and rare conditions, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.

Frequently asked questions

Is Revvity Inc overvalued or undervalued?

Bullrun's valuation model currently marks Revvity Inc as 21.4% overvalued.

What is Revvity Inc's market cap?

Revvity Inc's market capitalization is USD 12.41B.

What is Revvity Inc's P/E ratio?

Revvity Inc's price-to-earnings (P/E) ratio is 52.7.

Does Revvity Inc pay a dividend?

Revvity Inc has a dividend yield of 0.3%.

What does Revvity Inc do?

Revvity, Inc. provides health sciences solutions, technologies, and services. The company offers instruments, reagents, software, subscriptions, detection and imaging technologies, extended warranties, training and services;